Skip to main content
DNA Labs India

KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic Test

Short Name: KDR Gene Hemangioma NGS Test

Also known as: KDR Gene Mutation Test, Hemangioma Susceptibility Genetic Test, Familial Hemangioma NGS Test

KDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses NGS Technology on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks. Free home collection in 300+ cities across India.

NGS Genetic TestPediatric🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the KDR Gene Hemangioma NGS Genetic Test is to identify genetic mutations in the KDR gene that may increase susceptibility to capillary infantile hemangioma. This helps in confirming diagnosis, assessing familial risk, guiding treatment decisions, and facilitating genetic counseling for affected families.

Test Code
2878
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks
Fasting Required
No
Method
NGS Technology
Step 1

Sample Collection

No specific preparation required. Ensure patient identification and consent are obtained.

Method: Venipuncture or blood drop

Step 2

Laboratory Analysis

Collect blood sample via venipuncture or blood drop on FTA card under sterile conditions.

Step 3

Report Delivery

Label the sample correctly and transport to the laboratory at ambient temperature.

Timeline: 3 to 4 Weeks

Patient Instructions

1
Before the Test:Genetic counseling session to discuss test implications and draw a family pedigree chart.
2
During the Test:Blood sample collection and DNA extraction for NGS analysis.
3
After the Test:Report generation and delivery via online portal, email, or WhatsApp. Follow-up counseling recommended.

About This Test

Who Should Get This Test

The purpose of the KDR Gene Hemangioma NGS Genetic Test is to identify genetic mutations in the KDR gene that may increase susceptibility to capillary infantile hemangioma. This helps in confirming diagnosis, assessing familial risk, guiding treatment decisions, and facilitating genetic counseling for affected families.

How to Prepare

  • Use aseptic technique for blood collection
  • Avoid hemolysis by gentle handling
  • Store sample at room temperature if using FTA card
  • Provide clinical history and family pedigree chart

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Early genetic testing for KDR gene mutations can aid in the management and counseling of families with a history of capillary infantile hemangioma."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL of blood
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or blood drop

Sample Stability

Blood sample: Stable for 24 hours at room temperature
Extracted DNA: Stable for several days at 4°C
FTA card: Stable for long-term storage at room temperature
Sample Rejection Criteria:
  • Hemolyzed or clotted samples
  • Incorrectly labeled or unlabeled samples
  • Insufficient sample volume
  • Contaminated samples

Understanding Your Results

Results from the KDR Gene Hemangioma NGS Genetic Test indicate the presence or absence of genetic variants in the KDR gene. Interpretation should be done by a qualified genetic counselor in the context of clinical findings and family history.
📊

Pathogenic variant detected

Increased susceptibility to capillary infantile hemangioma. Genetic counseling and family screening recommended.

📊

Likely pathogenic variant detected

Probable increased risk. Further clinical correlation and counseling advised.

📊

No pathogenic variant detected

No KDR gene mutations identified. Does not rule out other genetic or non-genetic causes.

📊

Variant of uncertain significance

Clinical significance unclear. May require additional testing or family studies.

⚠️ When to Consult a Doctor:

Consult a doctor if you have a family history of hemangioma, notice skin lesions in infants, or receive positive genetic test results for further management and counseling.

Limitations

  • Test may not detect all genetic variants or mutations
  • Results require interpretation by a genetic counselor
  • Does not replace clinical diagnosis or imaging studies
  • Limited to KDR gene; other genes may be involved

Risks & Considerations

  • Minimal risk from blood draw, such as bruising or infection
  • Psychological impact of genetic results
  • Potential for uncertain findings requiring further investigation

Interfering Factors

  • Poor sample quality or contamination
  • Hemolyzed blood samples
  • Insufficient DNA quantity
  • Recent blood transfusions may affect results

Compare With Similar Tests

TestKDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic TestFLT4 Gene TestTEK Gene TestComprehensive Hemangioma PanelWhole Exome Sequencing
ComparisonKDR Gene Hemangioma, capillary infantile, familial, susceptibility to NGS Genetic Test

Frequently Asked Questions

What is the KDR Gene Hemangioma NGS Genetic Test?
It is a Next-Generation Sequencing test that analyzes the KDR gene for mutations associated with susceptibility to capillary infantile hemangioma.
Who should consider this test?
Individuals with a family history of hemangioma, infants with skin lesions suggestive of hemangioma, or those seeking genetic counseling for familial cases.
What is the cost of the test in India?
The test costs INR 20000, which includes sample collection and analysis.
How is the sample collected?
A blood sample is collected via venipuncture or a blood drop on an FTA card, with home collection available.
Is fasting required before the test?
No, fasting is not required for this genetic test.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection.
What do the test results indicate?
Results show whether pathogenic variants in the KDR gene are detected, indicating susceptibility to hemangioma.
Is the test accurate?
NGS technology provides high accuracy, but results should be interpreted by a genetic counselor in clinical context.
Are there any risks associated with the test?
Risks are minimal, mainly related to blood draw, such as bruising. Genetic results may have psychological implications.
Can the test be done at home?
Yes, free home sample collection is available for online bookings across India.
What should I do after receiving the results?
Consult a genetic counselor or healthcare provider to understand the results and discuss management options.
Is the test covered by insurance?
Coverage depends on the insurance provider; it is not typically covered under government schemes like PMJAY.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.